Date | Acquired company | Acquiring company | Amount | Related |
---|---|---|---|---|
2016-06-03 | Amarantus Diagnostics | Avant Diagnostics | Cancer - Oncology Neurodegenerative diseases Diagnostic |
|
2016-06-01 | Tokalas (USA - CA) | Oncternal Therapeutics (USA - CA) | Cancer - Oncology - Rare diseases | |
2016-05-31 | Effimune (France) | OSE Pharma (France) | Cancer - Oncology Immunotherapy |
|
2016-05-31 | Celator Pharmaceuticals (USA - NY) | Jazz Pharmaceuticals (Ireland) | $1.5 billion | Cancer - Oncology |
2016-05-31 | Italchimici (Italy) | Recordati (Italy) | € 130 million | Gastrointestinal diseases - Respiratory diseases |
2016-05-27 | FEI (USA - OR) | Thermo Fisher Scientific (USA - MA) | $4.2 billion | |
2016-05-13 | non-sterile, topicals-focused specialty and generics business of Renaissance Acquisition Holdings (Canada - USA) | Mylan (USA - PA) | $950 million (€835 million) | Generics |
2016-05-11 | Alizé Pharma II (France) | Jazz Pharmaceuticals (Ireland) | up to €18 million | Cancer - Oncology Rare diseases |
2016-05-10 | Kuecept (UK) | Aptuit (UK) | undisclosed | Technology - Services |
2016-05-05 | IMS Health (USA - CT) | Quintiles (USA - NC) | Clinical research Technology - Services |
|
2016-05-05 | Prime European Therapeuticals/Euticals (Italy) | AMRI (USA - NY) | € 315 million | Technology - Services manufacturing production |
2016-05-02 | Bioject Medical Technologies (USA) | Inovio Pharmaceuticals (USA - PA) | $5.5 million (€ 4.92 million) | Technology - Services |
2016-04-29 | 4SC Discovery (Germany) | BioNTech Small Molecules (Germany) | € 0.65 million | Technology - Services |
2016-04-28 | Stemcentrx (USA - CA) | Abbvie (USA -IL) | up to $ 9.8 billion (€ 8.65 billion) | Cancer - Oncology |
2016-04-28 | Rentschler Biotechnologie's Adeno-Associated Virus (AAV) manufacturing platform | Freeline Therapeutics (UK) | undisclosed | Manufacturing Production Gene therapy |
2016-04-25 | NTD (PerkinElmer’s U.S. prenatal screening laboratory services business) (USA - NY) | Eurofins Scientific (Luxembourg) | undisclosed | Diagnostic genomic testing |
2016-04-21 | Topokine Therapeutics (USA - MA) | Allergan (Ireland) | $85 million and success-based development and sales milestones | Ophtalmological diseases Aesthetic medicine |
2016-04-21 | Exquiron Biotech (Switzerland) | Aptuit (UK) | undisclosed | Technology - Services |
2016-04-18 | Cytonet's assets (Germany) | Promethera Biosciences (Belgium) | undisclosed | cell therapy regenerative medicine liver diseases hepatic diseases |
2016-04-15 | Crelux (Germany) | WuXi AppTec (China) | undisclosed | Technology - Services |